HEADER TRANSCRIPTION REGULATOR/INHIBITOR 31-MAY-17 5W0L TITLE CREBBP BROMODOMAIN IN COMPLEX WITH CPD10 (1-(3-(7-(DIFLUOROMETHYL)-6- TITLE 2 (1-METHYL-1H-PYRAZOL-4-YL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)-1- TITLE 3 (TETRAHYDRO-2H-PYRAN-4-YL)-1,4,6,7-TETRAHYDRO-5H-PYRAZOLO[4,3- TITLE 4 C]PYRIDIN-5-YL)ETHAN-1-ONE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BROMODOMAIN, UNP RESIDUES 1082-1197; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CREBBP, BROMODOMAIN, SMALL MOLECULE INHIBITOR, TRANSCRIPTION KEYWDS 2 REGULATOR-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 2 04-OCT-23 5W0L 1 REMARK REVDAT 1 07-MAR-18 5W0L 0 JRNL AUTH F.A.ROMERO,J.MURRAY,K.W.LAI,V.TSUI,B.K.ALBRECHT,L.AN, JRNL AUTH 2 M.H.BERESINI,G.DE LEON BOENIG,S.M.BRONNER,E.W.CHAN,K.X.CHEN, JRNL AUTH 3 Z.CHEN,E.F.CHOO,K.CLAGG,K.CLARK,T.D.CRAWFORD,P.CYR, JRNL AUTH 4 D.DE ALMEIDA NAGATA,K.E.GASCOIGNE,J.L.GROGAN, JRNL AUTH 5 G.HATZIVASSILIOU,W.HUANG,T.L.HUNSAKER,S.KAUFMAN,S.G.KOENIG, JRNL AUTH 6 R.LI,Y.LI,X.LIANG,J.LIAO,W.LIU,J.LY,J.MAHER,C.MASUI, JRNL AUTH 7 M.MERCHANT,Y.RAN,A.M.TAYLOR,J.WAI,F.WANG,X.WEI,D.YU,B.Y.ZHU, JRNL AUTH 8 X.ZHU,S.MAGNUSON JRNL TITL GNE-781, A HIGHLY ADVANCED POTENT AND SELECTIVE BROMODOMAIN JRNL TITL 2 INHIBITOR OF CYCLIC ADENOSINE MONOPHOSPHATE RESPONSE ELEMENT JRNL TITL 3 BINDING PROTEIN, BINDING PROTEIN (CBP). JRNL REF J. MED. CHEM. V. 60 9162 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28892380 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00796 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2747 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 39371 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.280 REMARK 3 FREE R VALUE TEST SET COUNT : 2077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.0879 - 3.8177 0.97 2569 118 0.1810 0.2258 REMARK 3 2 3.8177 - 3.0314 0.97 2455 173 0.1861 0.2089 REMARK 3 3 3.0314 - 2.6485 0.98 2451 135 0.2073 0.2643 REMARK 3 4 2.6485 - 2.4065 0.99 2487 161 0.1980 0.2273 REMARK 3 5 2.4065 - 2.2341 0.99 2505 149 0.1890 0.2240 REMARK 3 6 2.2341 - 2.1024 0.99 2501 101 0.1766 0.1991 REMARK 3 7 2.1024 - 1.9972 1.00 2497 144 0.1805 0.2192 REMARK 3 8 1.9972 - 1.9103 1.00 2487 128 0.1848 0.1787 REMARK 3 9 1.9103 - 1.8367 1.00 2482 158 0.1997 0.2797 REMARK 3 10 1.8367 - 1.7734 1.00 2521 112 0.1870 0.2307 REMARK 3 11 1.7734 - 1.7179 1.00 2475 130 0.2026 0.2784 REMARK 3 12 1.7179 - 1.6688 1.00 2549 103 0.2153 0.2596 REMARK 3 13 1.6688 - 1.6249 0.99 2432 141 0.2132 0.2384 REMARK 3 14 1.6249 - 1.5853 1.00 2473 177 0.2367 0.2451 REMARK 3 15 1.5853 - 1.5492 0.98 2410 147 0.2559 0.3155 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.930 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2046 REMARK 3 ANGLE : 1.019 2792 REMARK 3 CHIRALITY : 0.058 284 REMARK 3 PLANARITY : 0.008 406 REMARK 3 DIHEDRAL : 18.765 1274 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESSEQ 1084:1194) REMARK 3 ORIGIN FOR THE GROUP (A): -9.3086 -7.5788 -33.8200 REMARK 3 T TENSOR REMARK 3 T11: 0.1391 T22: 0.1118 REMARK 3 T33: 0.1255 T12: -0.0091 REMARK 3 T13: -0.0049 T23: -0.0071 REMARK 3 L TENSOR REMARK 3 L11: 1.0755 L22: 1.3287 REMARK 3 L33: 1.7811 L12: 0.1110 REMARK 3 L13: -0.1105 L23: -0.7398 REMARK 3 S TENSOR REMARK 3 S11: -0.0019 S12: -0.0268 S13: -0.0234 REMARK 3 S21: 0.0349 S22: 0.0489 S23: 0.0292 REMARK 3 S31: 0.0027 S32: -0.1292 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'B' AND (RESSEQ 1084:1194) REMARK 3 ORIGIN FOR THE GROUP (A): -34.1473 -18.0645 -6.6165 REMARK 3 T TENSOR REMARK 3 T11: 0.1477 T22: 0.1226 REMARK 3 T33: 0.1417 T12: 0.0054 REMARK 3 T13: -0.0106 T23: -0.0107 REMARK 3 L TENSOR REMARK 3 L11: 0.7910 L22: 1.2983 REMARK 3 L33: 1.9290 L12: -0.0957 REMARK 3 L13: 0.3176 L23: -0.7077 REMARK 3 S TENSOR REMARK 3 S11: 0.0037 S12: 0.0198 S13: 0.0058 REMARK 3 S21: -0.0534 S22: 0.0595 S23: 0.0654 REMARK 3 S31: 0.0223 S32: -0.1206 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W0L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228238. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39427 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 28.083 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.60300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDBID 5I8B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PH 5.5, 200-300 MM REMARK 280 KSCN, 21-25% PEG 3350, PH 6.5, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 17.02750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1050 REMARK 465 HIS A 1051 REMARK 465 HIS A 1052 REMARK 465 HIS A 1053 REMARK 465 HIS A 1054 REMARK 465 HIS A 1055 REMARK 465 HIS A 1056 REMARK 465 GLY A 1057 REMARK 465 SER A 1058 REMARK 465 LEU A 1059 REMARK 465 VAL A 1060 REMARK 465 PRO A 1061 REMARK 465 ARG A 1062 REMARK 465 GLY A 1063 REMARK 465 SER A 1064 REMARK 465 MET A 1065 REMARK 465 ASP A 1066 REMARK 465 TYR A 1067 REMARK 465 LYS A 1068 REMARK 465 ASP A 1069 REMARK 465 ASP A 1070 REMARK 465 ASP A 1071 REMARK 465 ASP A 1072 REMARK 465 LYS A 1073 REMARK 465 GLU A 1074 REMARK 465 ASN A 1075 REMARK 465 LEU A 1076 REMARK 465 TYR A 1077 REMARK 465 PHE A 1078 REMARK 465 GLN A 1079 REMARK 465 GLY A 1080 REMARK 465 SER A 1081 REMARK 465 LYS A 1082 REMARK 465 GLY A 1197 REMARK 465 MET B 1050 REMARK 465 HIS B 1051 REMARK 465 HIS B 1052 REMARK 465 HIS B 1053 REMARK 465 HIS B 1054 REMARK 465 HIS B 1055 REMARK 465 HIS B 1056 REMARK 465 GLY B 1057 REMARK 465 SER B 1058 REMARK 465 LEU B 1059 REMARK 465 VAL B 1060 REMARK 465 PRO B 1061 REMARK 465 ARG B 1062 REMARK 465 GLY B 1063 REMARK 465 SER B 1064 REMARK 465 MET B 1065 REMARK 465 ASP B 1066 REMARK 465 TYR B 1067 REMARK 465 LYS B 1068 REMARK 465 ASP B 1069 REMARK 465 ASP B 1070 REMARK 465 ASP B 1071 REMARK 465 ASP B 1072 REMARK 465 LYS B 1073 REMARK 465 GLU B 1074 REMARK 465 ASN B 1075 REMARK 465 LEU B 1076 REMARK 465 TYR B 1077 REMARK 465 PHE B 1078 REMARK 465 GLN B 1079 REMARK 465 GLY B 1080 REMARK 465 SER B 1081 REMARK 465 LYS B 1082 REMARK 465 GLY B 1197 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 ILE A1084 CG1 CG2 CD1 REMARK 470 SER A1195 OG REMARK 470 LYS B1083 CG CD CE NZ REMARK 470 ILE B1084 CG1 CG2 CD1 REMARK 470 SER B1195 OG REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1420 DISTANCE = 5.96 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9UD A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9UD B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5W0I RELATED DB: PDB DBREF 5W0L A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 5W0L B 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQADV 5W0L MET A 1050 UNP Q92793 INITIATING METHIONINE SEQADV 5W0L HIS A 1051 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS A 1052 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS A 1053 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS A 1054 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS A 1055 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS A 1056 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY A 1057 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER A 1058 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LEU A 1059 UNP Q92793 EXPRESSION TAG SEQADV 5W0L VAL A 1060 UNP Q92793 EXPRESSION TAG SEQADV 5W0L PRO A 1061 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ARG A 1062 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY A 1063 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER A 1064 UNP Q92793 EXPRESSION TAG SEQADV 5W0L MET A 1065 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP A 1066 UNP Q92793 EXPRESSION TAG SEQADV 5W0L TYR A 1067 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LYS A 1068 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP A 1069 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP A 1070 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP A 1071 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP A 1072 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LYS A 1073 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLU A 1074 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASN A 1075 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LEU A 1076 UNP Q92793 EXPRESSION TAG SEQADV 5W0L TYR A 1077 UNP Q92793 EXPRESSION TAG SEQADV 5W0L PHE A 1078 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLN A 1079 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY A 1080 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER A 1081 UNP Q92793 EXPRESSION TAG SEQADV 5W0L MET B 1050 UNP Q92793 INITIATING METHIONINE SEQADV 5W0L HIS B 1051 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS B 1052 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS B 1053 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS B 1054 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS B 1055 UNP Q92793 EXPRESSION TAG SEQADV 5W0L HIS B 1056 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY B 1057 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER B 1058 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LEU B 1059 UNP Q92793 EXPRESSION TAG SEQADV 5W0L VAL B 1060 UNP Q92793 EXPRESSION TAG SEQADV 5W0L PRO B 1061 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ARG B 1062 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY B 1063 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER B 1064 UNP Q92793 EXPRESSION TAG SEQADV 5W0L MET B 1065 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP B 1066 UNP Q92793 EXPRESSION TAG SEQADV 5W0L TYR B 1067 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LYS B 1068 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP B 1069 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP B 1070 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP B 1071 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASP B 1072 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LYS B 1073 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLU B 1074 UNP Q92793 EXPRESSION TAG SEQADV 5W0L ASN B 1075 UNP Q92793 EXPRESSION TAG SEQADV 5W0L LEU B 1076 UNP Q92793 EXPRESSION TAG SEQADV 5W0L TYR B 1077 UNP Q92793 EXPRESSION TAG SEQADV 5W0L PHE B 1078 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLN B 1079 UNP Q92793 EXPRESSION TAG SEQADV 5W0L GLY B 1080 UNP Q92793 EXPRESSION TAG SEQADV 5W0L SER B 1081 UNP Q92793 EXPRESSION TAG SEQRES 1 A 148 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 A 148 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 A 148 LEU TYR PHE GLN GLY SER LYS LYS ILE PHE LYS PRO GLU SEQRES 4 A 148 GLU LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU SEQRES 5 A 148 TYR ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO SEQRES 6 A 148 VAL ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP SEQRES 7 A 148 ILE VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG SEQRES 8 A 148 LYS LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR SEQRES 9 A 148 VAL ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU SEQRES 10 A 148 TYR ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER SEQRES 11 A 148 LYS LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL SEQRES 12 A 148 MET GLN SER LEU GLY SEQRES 1 B 148 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 B 148 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 B 148 LEU TYR PHE GLN GLY SER LYS LYS ILE PHE LYS PRO GLU SEQRES 4 B 148 GLU LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU SEQRES 5 B 148 TYR ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO SEQRES 6 B 148 VAL ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP SEQRES 7 B 148 ILE VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG SEQRES 8 B 148 LYS LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR SEQRES 9 B 148 VAL ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU SEQRES 10 B 148 TYR ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER SEQRES 11 B 148 LYS LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL SEQRES 12 B 148 MET GLN SER LEU GLY HET 9UD A1201 37 HET 9UD B1201 37 HETNAM 9UD 1-{3-[7-(DIFLUOROMETHYL)-6-(1-METHYL-1H-PYRAZOL-4-YL)- HETNAM 2 9UD 3,4-DIHYDROQUINOLIN-1(2H)-YL]-1-(OXAN-4-YL)-1,4,6,7- HETNAM 3 9UD TETRAHYDRO-5H-PYRAZOLO[4,3-C]PYRIDIN-5-YL}ETHAN-1-ONE FORMUL 3 9UD 2(C27 H32 F2 N6 O2) FORMUL 5 HOH *243(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1116 GLY A 1121 1 6 HELIX 4 AA4 ASP A 1124 VAL A 1129 1 6 HELIX 5 AA5 ASP A 1134 THR A 1144 1 11 HELIX 6 AA6 GLU A 1149 ASN A 1168 1 20 HELIX 7 AA7 SER A 1172 LEU A 1196 1 25 HELIX 8 AA8 LYS B 1086 ARG B 1103 1 18 HELIX 9 AA9 SER B 1108 ARG B 1112 5 5 HELIX 10 AB1 ASP B 1116 GLY B 1121 1 6 HELIX 11 AB2 ASP B 1124 VAL B 1129 1 6 HELIX 12 AB3 ASP B 1134 THR B 1144 1 11 HELIX 13 AB4 GLU B 1149 ASN B 1168 1 20 HELIX 14 AB5 SER B 1172 LEU B 1196 1 25 CISPEP 1 ASP A 1105 PRO A 1106 0 7.34 CISPEP 2 ASP B 1105 PRO B 1106 0 10.34 SITE 1 AC1 7 LEU A1109 PRO A1110 ASN A1168 ARG A1173 SITE 2 AC1 7 VAL A1174 HOH A1311 HOH A1361 SITE 1 AC2 8 LEU B1109 PRO B1110 ASN B1168 ARG B1173 SITE 2 AC2 8 VAL B1174 HOH B1307 HOH B1362 HOH B1366 CRYST1 49.648 34.055 80.887 90.00 90.01 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020142 0.000000 0.000005 0.00000 SCALE2 0.000000 0.029364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012363 0.00000